Box of 5  Tests

The Rapid Response® Influenza AB + COVID-19 Antigen– 3 in 1 Test is an in vitro lateral flow immunoassay for the detection and differentiation of nucleoprotein antigens from SARS-CoV-2, Influenza A and/or Influenza B. This test detects for respiratory pathogens in anterior nasal or nasopharyngeal swab specimens from individuals suspected of COVID-19 or Influenza AB within the first 7 days of symptoms onset.

The Rapid Response® Influenza AB + COVID-19 Antigen– 3 in 1 Test is authorized under the Health Canada Interim Order (IO #356389).

This test is suitable for use by healthcare professionals and laboratory personnel trained to perform the test.

• Covid 19 Sensitivity – 93.6%; Specificity – 99.7%,
• Influenza A Sensitivity – 94.3%; Specificity – 99.7%,
• Influenza B Sensitivity – 93.3%; Specificity – 99.7%,
• Results in 15 minutes
• Can be used reliably with or without virus symptoms
• Variant and combination sensitive
• Health Canada authorized